UnitedHealth Group (UNH Quick QuoteUNH - Free Report) reported $111.72 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 2%. EPS of $7.23 for the same period compares to $7.20 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $109.45 billion, representing a surprise of +2.07%. The company delivered an EPS surprise of +11.92%, with the consensus EPS estimate being $6.46.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Operating Statistics - Medical Care Ratio: 83.9% versus 85.7% estimated by eight analysts on average.
• UnitedHealthcare Customer Profile - People Served - Total Commercial - Domestic: 30.07 million versus the five-analyst average estimate of 29.15 million.
• UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Risk-based: 7.73 million versus the five-analyst average estimate of 7.04 million.
• UnitedHealthcare Customer Profile - People Served - Commercial - Domestic - Fee-based: 22.34 million compared to the 22.11 million average estimate based on five analysts.
• Revenues- Investment and other income: $1.13 billion versus the eight-analyst average estimate of $975.47 million. The reported number represents a year-over-year change of +9.5%.
• Revenues- Products: $13.25 billion versus $13.54 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +1.6% change.
• Revenues- Services: $9.78 billion versus $9.25 billion estimated by eight analysts on average. Compared to the year-ago quarter, this number represents a +9% change.
• Revenues- Premiums: $87.56 billion versus the eight-analyst average estimate of $86.12 billion. The reported number represents a year-over-year change of +1.2%.
• Revenues- Optum Insight: $5.13 billion versus the six-analyst average estimate of $5.03 billion. The reported number represents a year-over-year change of +10.7%.
• Revenues- Optum Rx: $35.74 billion versus $35.05 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +1.7% change.
• Revenues- Optum Health: $24.11 billion versus $22.77 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a -4.7% change.
• Revenues- UnitedHealthcare- Total: $86.27 billion compared to the $85.08 billion average estimate based on six analysts. The reported number represents a change of +2% year over year.

View all Key Company Metrics for UnitedHealth here>>>

Shares of UnitedHealth have returned +20% over the past month versus the Zacks S&P 500 composite's +9.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.